Patrick Stone, MD
Vascular Surgery · Nashville, TNNPI 1851472682
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $32,918 of the $45,652 with a category attached, or 72.1%. W. L. Gore & Associates, Inc. accounts for 76.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $19,328 and has fallen 69.0% since, to $5,990 in 2025. Among vascular surgery clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $530.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$35K
- Penumbra, Inc.$6K
- Abbott$2K
- Medtronic$1K
- Cook Medical LLC$604
- Silk Road Medical, Inc.$392
- plus $415 from 8 others
Across 1 payment — averaging $8700.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$9K
What the payments were for
- Consulting fees$32,91872%
- Speaking & faculty fees$4,0009%
- Travel & lodging$2,1135%
- Food & beverage$6,62115%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 20 | $34,927 |
| Penumbra, Inc. | 9 | $5,748 |
| Abbott | 17 | $2,077 |
| Medtronic(2 entities) | 14 | $1,489 |
| Cook Medical LLC | 9 | $604 |
| Silk Road Medical, Inc. | 4 | $392 |
| Johnson & Johnson(2 entities) | 3 | $130 |
| Terumo Medical Corporation | 2 | $113 |
| Centerline Biomedical Inc. | 1 | $46 |
| Saranas, Inc. | 1 | $45 |
| Surmodics, Inc. | 3 | $30 |
| Bard Peripheral Vascular, Inc. | 1 | $26 |
| Atricure, Inc. | 1 | $19 |
| Merit Medical Systems Inc | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product in Development$32,918
- Indigo System$4,000
- Penumbra System$1,501
- ELLIPSYS VASCULAR ACCESS SYSTEM$1,011
- SUPERA$437
- ESPRIT$436
- GORE VIABAHN VBX Balloon Expandable Endo$434
- GORE TAG Conformable Thoracic Endoprosthesis$382
- JETI$321
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$307
- JETi All In One Non-Sterile Kit$301
- Cook Medical AAA$260
- GORE EXCLUDER AAA Endoprosthesis$219
- ENROUTE Transcarotid Neuroprotection System$175
- ENROUTE Transcarotid Stent System$175
- ENHANCE Transcarotid Peripheral Access Kit$175
- ENROUTE 0.014 Guidewire$175
- Supera peripheral stent system$164
- OMNILINK ELITE$156
- GORE VIABAHN Endoprosthesis with Heparin$143
How this compares
$45,652 in reported general payments places this provider in the 90th percentile of 117 vascular surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 19 | $28,224 |
| EliquisApixaban | 12 | $8,853 |
| ClopidogrelClopidogrel Bisulfate | 35 | $382 |
| Cilostazol | 11 | $195 |
| Atorvastatin Calcium | 21 | $163 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $130 | $28,22419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 117 vascular surgery providers in Tennessee.
Other vascular surgery in Nashville
- Daniel ClairNashville$993K
- Allen LeeNashville$39K
- Julia BollNashville$36K
- Thomas NaslundNashville$31K
- Lauren FryeNashville$20K
- Patrick RyanNashville$19K
- Jim Bob FaulkNashville$13K
- Mary NallyNashville$10K
- Sergio Sastriques DunlopNashville$10K
- Ziad Al AdasNashville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.